HDAC3 and colorectal carcinoma: Among them, HDAC3 inhibition by RGFP966 produced the most pronounced ferroptotic phenotype, highlighting HDAC3 as a potential epigenetic target for sensitizing CRC cells to ferroptosis-inducing therapies.